Updated December 10, 2020 5:50 p.m. EST
By WRAL reporter Kasey Cunningham and PolitiFact reporter Paul Specht
Durham, N.C. A Food and Drug Administration advisory committee on Thursday evening recommended approval of a COVID-19 vaccine developed by Pfizer and BioNTech.
The vote capped an day-long meeting where FDA regulators interviewed Pfizer executives, as well as experts at the U.S. Centers for Disease Control and Prevention.
In a 17-4 vote, the committee decided the benefits of the vaccine outweigh the potential risks to people aged 16 and older. Prior to the vote, some committee members sought to exclude 16-and17-year olds from the recommendation, citing a lack of data for that age group.
Pfizer Stock: FDA Panel Slated To Weigh Coronavirus Vaccine | Investor s Business Daily investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
FDA panel recommends approval of Pfizer s coronavirus vaccine for emergency use mlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mlive.com Daily Mail and Mail on Sunday newspapers.
Once the FDA approves the Pfizer-BioNTech vaccine for emergency use authorization, Duke Hospital is among the North Carolina facilities that will receive the first doses.
Pfizer leaders present vaccine data to FDA :: WRAL com wral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wral.com Daily Mail and Mail on Sunday newspapers.